Wednesday, 28 April 2010

Narbon




Narbon may be available in the countries listed below.


Ingredient matches for Narbon



Hydroxychloroquine

Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Narbon in the following countries:


  • Argentina

International Drug Name Search

Canasa


Canasa is a brand name of mesalamine, approved by the FDA in the following formulation(s):


CANASA (mesalamine - suppository; rectal)



  • Manufacturer: AXCAN

    Approval date: November 5, 2004

    Strength(s): 1GM [RLD]

Has a generic version of Canasa been approved?


No. There is currently no therapeutically equivalent version of Canasa available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Canasa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Canasa.

See also...

  • Canasa Suppositories Consumer Information (Wolters Kluwer)
  • Canasa rectal Consumer Information (Cerner Multum)
  • Canasa Rectal Advanced Consumer Information (Micromedex)
  • Mesalamine Controlled-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Mesalamine Enema Consumer Information (Wolters Kluwer)
  • Mesalamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Mesalamine Suppositories Consumer Information (Wolters Kluwer)
  • Mesalamine Consumer Information (Cerner Multum)
  • Mesalamine rectal Consumer Information (Cerner Multum)
  • Mesalamine Advanced Consumer Information (Micromedex)
  • Mesalamine Rectal Advanced Consumer Information (Micromedex)
  • SfRowasa Advanced Consumer Information (Micromedex)
  • Mesalamine AHFS DI Monographs (ASHP)

Monday, 26 April 2010

Aquaject A




Aquaject A may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Aquaject A



Retinol

Retinol is reported as an ingredient of Aquaject A in the following countries:


  • South Africa

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Aquaject A in the following countries:


  • South Africa

International Drug Name Search

Tuesday, 13 April 2010

Imidacloprid




In some countries, this medicine may only be approved for veterinary use.

CAS registry number (Chemical Abstracts Service)

0105827-78-9

Chemical Formula

C9-H10-Cl-N5-O2

Molecular Weight

255

Therapeutic Category

Ectoparasiticide

Chemical Name

2-Imidazolidinimine, 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-

Foreign Name

  • Imidacloprid (German)

Brand Names

  • Advantage Multi (Imidacloprid and Moxidectin (veterinary use))
    Bayer Healthcare LLC, United States


  • Advantage (veterinary use)
    Bayer, Poland; Bayer, Sweden; Bayer Animal, Germany; Bayer Animal, Netherlands; Bayer Animal, Norway; Bayer Animal, New Zealand; Bayer Animal Health, Belgium; Bayer Animal Health, United Kingdom; Bayer Animal Health, Ireland; Bayer Animal Health, Luxembourg; Bayer Animal Health, South Africa; Bayer Australia Ltd Animal Health, Australia; Bayer Portugal, SA., Portugal; Bayer Sanità Animale, Italy; Bayer Santé Animale Division Santé Animale, France; Bayer Tiergesundheit, Austria


  • Advantage DUO (Imidacloprid and Ivermectin (veterinary use))
    Bayer Healthcare LLC, United States


  • Advantix (Imidacloprid and Permethrin (veterinary use))
    Bayer, Poland; Bayer Animal, Germany; Bayer Animal Health, Luxembourg; Bayer Animal Health, South Africa; Bayer Australia Ltd Animal Health, Australia; Bayer Santé Animale Division Santé Animale, France; Bayer Tiergesundheit, Austria; Provet, Switzerland


  • Advantix (veterinary use)
    Bayer Animal Health, United Kingdom


  • Advocate (Imidacloprid and Moxidectin (veterinary use))
    Bayer, Sweden; Bayer Animal, Germany; Bayer Animal, Norway; Bayer Animal, New Zealand; Bayer Australia Ltd Animal Health, Australia; Bayer Healthcare, Austria; Bayer Santé Animale Division Santé Animale, France; Provet, Switzerland


  • Bayvantage (veterinary use)
    Provet, Switzerland


  • Bayvantic (Imidacloprid and Permethrin (veterinary use))
    Bayer Animal, Norway; Orion, Finland


  • Biocanispot (veterinary use)
    Véto-Centre, France


  • Bolfo Gold Vlooiendruppels (veterinary use)
    Bayer Animal, Netherlands

International Drug Name Search

Amikacina




Amikacina may be available in the countries listed below.


Ingredient matches for Amikacina



Amikacin

Amikacina (DCIT) is known as Amikacin in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 9 April 2010

Primalan




Primalan may be available in the countries listed below.


Ingredient matches for Primalan



Mequitazine

Mequitazine is reported as an ingredient of Primalan in the following countries:


  • Algeria

  • Argentina

  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Latvia

  • Luxembourg

  • Madagascar

  • Mali

  • Mauritania

  • Mexico

  • Niger

  • Philippines

  • Portugal

  • Romania

  • Russian Federation

  • Senegal

  • Togo

  • Tunisia

  • Zaire

International Drug Name Search

Tuesday, 6 April 2010

Orciprenalina




Orciprenalina may be available in the countries listed below.


Ingredient matches for Orciprenalina



Orciprenaline

Orciprenalina (DCIT) is also known as Orciprenaline (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.